# Retatrutide FAQ: Common Questions About the Triple-Receptor Agonist | Doctor Retatrutide

> Retatrutide frequently asked questions: what it is, how it works, FDA approval status, dosage data from trials, side effects, half-life, and TRIUMPH Phase 3 results.

Retatrutide is the investigational triple-receptor agonist in Lilly's Phase 3 TRIUMPH program. These [frequently asked questions](/faq) address the most common topics across mechanism, clinical trial data, safety, and regulatory status.



---

A cinematic index of the Phase 2 and Phase 3 retatrutide trial record — primary sources only, no clinic, no prescription.